All Articles

Facing a 74% stock drop and legal challenges, benefits giant Alight brings in an external CEO known for revenue growth to steer a difficult turnaround.

New data reveals a surge in US charity, driven not just by generosity, but by innovative tools like Donor-Advised Funds that amplify donor impact.

Elite universities are now adopting B2B marketing playbooks. See how Cambridge is using data-driven engagement tech to revolutionize MBA recruitment.

With the Cedar Fair merger complete, can new CEO John Reilly leverage his operational expertise to revive underperforming parks and win the theme park wars?

Liberty Defense taps a specialized partner for HEXWAVE deployment, a strategic move to overcome financial hurdles and accelerate growth in the security market.

With cash dwindling and Nasdaq warnings, Profusa bets its future on late-breaking clinical data for its revolutionary tissue-monitoring implant.

Inside a historic German wind tunnel, an unsung industrial hero is quietly accelerating the future of supersonic flight. Here’s how it works.

The strategic acquisition merges advanced AI and workflow automation with compliance, aiming to shift the energy sector from reactive to predictive operations.

Day One's pediatric cancer drug OJEMDA offers more than hope; its unique treatment model signals a seismic shift in pharmaceutical logistics and operations.

A new partnership for America's 250th anniversary goes beyond sponsorship, aiming to define the future of American ingenuity and honor its veteran innovators.

Record home price cuts signal a major market shift. We go beyond the headlines to analyze if this is a healthy correction or a warning sign.

A hedge fund's 1.44% derivative stake in Dowlais Group reveals the complex financial strategies shaping the blockbuster American Axle merger.

Kellanova, Walmart, and Indigo Ag are paying farmers to go green. But is their new partnership a true blueprint for sustainable agriculture or just a drop in the bucket?

A routine investment announcement offers a window into the economic pressures shaping household stability and the future of Canadian public services.

Chery Group's new EV brand, LEPAS, arrives in South Africa with premium ambitions. Can its 'elegance' philosophy overcome infrastructure hurdles and fierce competition?

Activist investor Engaged Capital demands records from BlackLine's board over a rejected $4.5B SAP offer, setting the stage for a major proxy battle.

Manulife announced its estimated 2025 reinvested ETF capital gains. Learn what this "phantom income" means for your portfolio and your tax bill.

Manulife's estimated December ETF distributions are out, offering a crucial glimpse for income seekers planning for 2026 in a complex market.

RAID's blockbuster crossover with Alien and Predator isn't just fan service. It's a calculated strategy driving revenue and redefining player engagement.

With a leaner profile, BioLineRx bets on a novel glioblastoma drug while advancing its diverse pipeline. A deep dive into the strategy and the science.